Workflow
LBPMedicine(688393)
icon
Search documents
安必平收盘下跌6.87%,滚动市盈率1298.45倍,总市值29.05亿元
Sou Hu Cai Jing· 2025-08-08 11:58
Group 1 - The core viewpoint of the article highlights the significant decline in the stock price of Anbiping, which closed at 31.05 yuan, down 6.87%, with a rolling PE ratio of 1298.45 times, indicating a substantial overvaluation compared to the industry average [1] - Anbiping's total market capitalization is reported at 2.905 billion yuan, which is considerably lower than the industry average market capitalization of 11.731 billion yuan [2] - The company operates in the medical device sector, focusing on tumor screening and diagnostic reagents, automation equipment, and AI-assisted diagnostic software [1] Group 2 - As of March 31, 2025, Anbiping has 10,309 shareholders, an increase of 4,393 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The latest quarterly report for Q1 2025 shows that Anbiping achieved a revenue of 72.5435 million yuan, a year-on-year decrease of 28.51%, and a net loss of approximately 11.064 million yuan, reflecting a year-on-year decline of 238.49% [1] - The company's gross profit margin stands at 61.97%, indicating a relatively high profitability despite the revenue decline [1]
医疗器械行业8日主力净流出6.11亿元,安必平、东富龙居前
Sou Hu Cai Jing· 2025-08-08 07:56
来源:金融界 主力资金净流出居前的分别为安必平(1174.99万元)、东富龙(1070.65万元)、安杰思(995.13万 元)、微电生理(983.9万元)、可孚医疗(916.41万元)。 序号代码名称最新价涨跌幅主力净流入主力净占比1300760迈瑞医疗230.71-0.031.07亿元7.18%2300003 乐普医疗17.276.931.07亿元5.73%3301363美好医疗20.037.175599.57万元11.04%4603987康德莱 9.235.734851.48万元12.43%5870199倍益康42.581.383949.32万元7.52%6002551尚荣医疗4.649.953736.73 万元22.93%7688068热景生物243.022.543614.97万元6.9%8688314康拓医疗40.08.113278.73万元 15.1%9688108赛诺医疗20.4420.022762.62万元19.98%10832278鹿得医疗12.484.962727.93万元13.05% 8月8日,医疗器械行业上涨0.93%,今日主力资金流出6.11亿元,成分股59只上涨,39只下跌。 ...
安必平收盘上涨1.18%,滚动市盈率1394.21倍,总市值31.20亿元
Sou Hu Cai Jing· 2025-08-07 11:45
Company Overview - Anbiping's closing price on August 7 was 33.34 yuan, with an increase of 1.18%, resulting in a rolling PE ratio of 1394.21 times, the lowest in 86 days, and a total market capitalization of 3.12 billion yuan [1] - The company's main business includes tumor screening and diagnostic reagents, automation equipment, and auxiliary diagnostic artificial intelligence software [1] Financial Performance - In the first quarter of 2025, Anbiping reported operating revenue of 72.54 million yuan, a year-on-year decrease of 28.51%, and a net loss of approximately 11.06 million yuan, a year-on-year decline of 238.49%, with a gross profit margin of 61.97% [1] Shareholder Information - As of March 31, 2025, Anbiping had 10,309 shareholders, an increase of 4,393 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 54.79 times, with a median of 37.86 times, placing Anbiping at the 123rd position in the industry ranking [1][2] - Other companies in the industry have significantly lower PE ratios, with the highest being 20.27 times for Sanxin Medical, indicating a substantial disparity compared to Anbiping [2]
医疗器械板块8月1日涨0.18%,利德曼领涨,主力资金净流入4010.8万元
Market Overview - On August 1, the medical device sector rose by 0.18% compared to the previous trading day, with Lidman leading the gains [1] - The Shanghai Composite Index closed at 3559.95, down 0.37%, while the Shenzhen Component Index closed at 10991.32, down 0.17% [1] Top Gainers in Medical Device Sector - Lidman (300289) closed at 8.45, up 20.03% with a trading volume of 588,100 shares and a transaction value of 496 million yuan [1] - Rejing Bio (688068) closed at 216.50, up 11.03% with a trading volume of 44,000 shares and a transaction value of 948 million yuan [1] - Guanwu Bio (300238) closed at 19.00, up 9.20% with a trading volume of 470,900 shares and a transaction value of 878 million yuan [1] - Yingke Medical (300677) closed at 37.28, up 8.53% with a trading volume of 447,500 shares and a transaction value of 1.643 billion yuan [1] - Other notable gainers include Zhonghong Medical (300981), Sainuo Medical (688108), and Kemei Diagnosis (688468) with respective increases of 8.05%, 6.70%, and 6.66% [1] Top Losers in Medical Device Sector - Huakang Clean (301235) closed at 33.10, down 5.97% with a trading volume of 158,600 shares [2] - Kangtai Medical (300869) closed at 19.80, down 4.35% with a trading volume of 284,800 shares and a transaction value of 571 million yuan [2] - Other significant decliners include XD Chunli Medical (688236), Haooubo (688656), and Huqiang Technology (688151) with respective declines of 3.67%, 3.13%, and 3.10% [2] Capital Flow in Medical Device Sector - On the same day, the medical device sector saw a net inflow of 40.108 million yuan from institutional investors, while retail investors experienced a net outflow of 93.3185 million yuan [2][3] - Notable net inflows from institutional investors included Lepu Medical (300003) with 57.2395 million yuan and Guanwu Bio (300238) with 57.033 million yuan [3] - Conversely, significant net outflows from retail investors were observed in Lepu Medical (-82.3375 million yuan) and Guanwu Bio (-11.5 million yuan) [3]
71只股中线走稳 站上半年线
| 000820 | *ST节能 | 3.70 | 2.42 | 2.75 | 2.80 | 1.71 | | --- | --- | --- | --- | --- | --- | --- | | 301191 | 菲菱科 | 2.33 | 9.17 | 90.19 | 91.69 | 1.66 | | | 思 | | | | | | | 000681 | 视觉中 国 | 5.38 | 11.45 | 21.38 | 21.73 | 1.62 | | 002230 | 科大讯 飞 | 1.59 | 2.03 | 48.41 | 49.18 | 1.58 | | 300115 | 长盈精 密 | 9.87 | 13.64 | 22.57 | 22.93 | 1.58 | | 688766 | 普冉股 份 | 3.1 1 | 5.06 | 68.97 | 70.04 | 1.55 | | 688152 | 麒麟信 安 | 3.92 | 7.78 | 46.19 | 46.88 | 1.50 | | 301210 | 金杨股 份 | 2.69 | 13.61 | 42.18 | 42.80 | 1.46 | | ...
安必平多款产品获得欧盟CE认证
Zhong Zheng Wang· 2025-07-30 03:16
Core Points - Company announced that five products have received EU CE certification, including a film dyeing integrated machine, an automatic slide maker, and three consumable products [1] - The certification allows these products to be sold in the EU and European Economic Area (EEA) markets, facilitating entry into other international markets that recognize or reference EU standards [1] - The certificates for the certified products are valid from July 2025 and are long-term [1] Market Expansion - The actual sales performance of the certified products will depend on market promotion effectiveness, brand influence, and actual market demand, indicating significant uncertainty [1] - The company stated that obtaining the EU In Vitro Diagnostic Medical Device Regulation (IVDR) certification will aid in entering other international markets that recognize EU standards, further broadening the overseas application scenarios for these products [1] - The company has already obtained market access qualifications in multiple countries and regions, including Japan, the EU, Ukraine, Ecuador, and Vietnam, and plans to accelerate the expansion of its overseas access footprint [1]
广州安必平医药科技股份有限公司关于自愿披露公司产品获得欧盟CE认证的公告
Group 1 - The company, Guangzhou Anbiping Pharmaceutical Technology Co., Ltd., has recently obtained CE certification for five of its products, allowing them to be sold in the EU and European Economic Area (EEA) markets [1] - The certification will facilitate entry into other international markets that recognize or reference EU standards, thereby broadening the overseas application scenarios for the company's products [1] - The company has also secured market access qualifications in multiple countries and regions, including Japan, Ukraine, Ecuador, and Vietnam, and plans to accelerate its international expansion [1]
安必平:公司产品获得欧盟CE认证
Zheng Quan Ri Bao Wang· 2025-07-29 13:11
证券日报网讯7月29日晚间,安必平发布公告称,公司5个产品近期获得欧盟CE认证,获证产品可在欧 盟及欧洲经济区(EEA)市场进行销售,并有助于进入其他认可或参考欧盟标准的国际市场。 ...
安必平(688393.SH)多项产品获欧盟CE认证
智通财经网· 2025-07-29 09:16
本次获得认证的产品具体为:制片染色一体机 LBP NovaPrime SD 90 Slide Processor、全自动封片机 LBP Auto-Coverslipper、LBP-4032 耗材伴侣 LBC SD Testmate-4032、LBP-2390 耗材伴侣(妇科) LBC SD Testmate-2390 G、LBP-2364 耗材伴侣(妇科) LBC MB Testmate-2364 G。 智通财经APP讯,安必平(688393.SH)公告,公司5个产品近期获得欧盟CE认证,获证产品可在欧盟及欧 洲经济区(EEA)市场进行销售,并有助于进入其他认可或参考欧盟标准的国际市场。 ...
安必平(688393) - 关于自愿披露公司产品获得欧盟CE认证的公告
2025-07-29 09:15
一、获得资质的具体情况 二、对公司的影响 证券代码:688393 证券简称:安必平 公告编号:2025-032 广州安必平医药科技股份有限公司 关于自愿披露公司产品获得欧盟 CE 认证的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 广州安必平医药科技股份有限公司(以下简称"公司")5 个产品近期获得 欧盟 CE 认证,获证产品可在欧盟及欧洲经济区(EEA)市场进行销售,并有助 于进入其他认可或参考欧盟标准的国际市场,现将具体情况公告如下: | 序号 | 产品名称 | 证书编号 | 证书有效期 | 技术平台 | | --- | --- | --- | --- | --- | | 1 | 制片染色一体机 LBP NovaPrime SD 90 Slide Processor | CIBG-20252263 | 2025.7-长期 | LBP | | 2 | 全自动封片机 LBP Auto-Coverslipper | CIBG-20252263 | 2025.7-长期 | 常规病理 | | 3 | 耗材伴侣 LBP-4 ...